Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CTL-019
CTL-019
Novartis chief Jimenez touts two top PhIII drug prospects
Endpoints
Wed, 01/18/17 - 10:07 am
Novartis
Joe Jimenez
CTL-019
BAF-312
CAR-T
progressive MS
multiple sclerosis
Novartis' Big News at ASH? It's Still in the CAR-T Race
Motley Fool
Fri, 12/16/16 - 11:28 am
Novartis
ASH
CAR-T
CTL-019
Novartis promises a speedy CAR-T pitch, boasts about its slate of blockbusters-to-be
Endpoints
Tue, 10/25/16 - 10:10 am
Novartis
CAR-T
CTL-019
acute lymphoblastic leukemia
diffuse large B-cell lymphoma
Novartis debates how to crack sales code for CAR-T therapy
BioPharma Dive
Tue, 05/17/16 - 11:55 am
Novartis
CAR-T
CTL-019
acute lymphoblastic leukemia